![](/img/cover-not-exists.png)
Impact of clinical syndrome acuity on the differential response to two glycoprotein IIb/IIIa inhibitors in patients undergoing coronary stenting: the TARGET trial
Gregg W. Stone, David J. Moliterno, Michel Bertrand, Franz-Joseph Neumann, Howard C. Herrmann, Eric R. Powers, Cindy L. Grines, David J. Cohen, Eric A. Cohen, Marc Cohen, Marion Piedmonte, Pete M. DiBVolume:
39
Year:
2002
Language:
english
DOI:
10.1016/s0735-1097(02)80091-2
File:
PDF, 144 KB
english, 2002